In pancreatic, oesophageal and triple negative breast cancers, Grb7 drives migratory and invasive events, with Grb7 knockdown inhibiting these processes when tested in vitro (Tanaka et al., 1997, 2000, 2006; Giricz et al., 2012). Here, GRB7 is linked to triple-negative breast carcinoma.